Raymond James & Associates’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.91M Buy
561,371
+34,556
+7% +$118K ﹤0.01% 2245
2024
Q2
$2.46M Buy
526,815
+174,993
+50% +$817K ﹤0.01% 2032
2024
Q1
$2.61M Buy
351,822
+92,763
+36% +$688K ﹤0.01% 1992
2023
Q4
$2.62M Sell
259,059
-15,244
-6% -$154K ﹤0.01% 1928
2023
Q3
$2.14M Buy
274,303
+14,994
+6% +$117K ﹤0.01% 1973
2023
Q2
$2.13M Buy
259,309
+154,566
+148% +$1.27M ﹤0.01% 2007
2023
Q1
$759K Buy
104,743
+7,516
+8% +$54.5K ﹤0.01% 2623
2022
Q4
$862K Buy
97,227
+11,319
+13% +$100K ﹤0.01% 2515
2022
Q3
$1.05M Sell
85,908
-52,571
-38% -$644K ﹤0.01% 2354
2022
Q2
$1.64M Sell
138,479
-21,642
-14% -$256K ﹤0.01% 2111
2022
Q1
$3.05M Buy
160,121
+100,971
+171% +$1.92M ﹤0.01% 1842
2021
Q4
$1.57M Sell
59,150
-4,711
-7% -$125K ﹤0.01% 2328
2021
Q3
$2.62M Buy
63,861
+498
+0.8% +$20.5K ﹤0.01% 1905
2021
Q2
$3.59M Sell
63,363
-18,464
-23% -$1.05M ﹤0.01% 1721
2021
Q1
$3.44M Buy
81,827
+20,485
+33% +$860K ﹤0.01% 1672
2020
Q4
$4.3M Sell
61,342
-20,192
-25% -$1.42M ﹤0.01% 1420
2020
Q3
$2.29M Sell
81,534
-18,502
-18% -$519K ﹤0.01% 1665
2020
Q2
$2.96M Buy
100,036
+5,380
+6% +$159K ﹤0.01% 1488
2020
Q1
$1.88M Buy
94,656
+42,318
+81% +$839K ﹤0.01% 1609
2019
Q4
$1.55M Sell
52,338
-7,806
-13% -$231K ﹤0.01% 1991
2019
Q3
$1.37M Buy
60,144
+1,296
+2% +$29.5K ﹤0.01% 1995
2019
Q2
$1.46M Buy
58,848
+42,050
+250% +$1.04M ﹤0.01% 1984
2019
Q1
$411K Sell
16,798
-11,548
-41% -$283K ﹤0.01% 2783
2018
Q4
$645K Sell
28,346
-5,432
-16% -$124K ﹤0.01% 2370
2018
Q3
$1.08M Buy
33,778
+1,505
+5% +$47.9K ﹤0.01% 2208
2018
Q2
$1.16M Buy
32,273
+172
+0.5% +$6.16K ﹤0.01% 2094
2018
Q1
$1.06M Buy
+32,101
New +$1.06M ﹤0.01% 2090